Life sciences developer BioMed Realty’s plans for a sprawling 600,000 sq ft science campus in Cambridge have been approved.
Located at Fulbourn Road, the Cambridge International Technology Park will consist of around five major laboratory and office buildings with multistorey car parking and will be built in several phases.
Designed by British architect Scott Brownrigg, it is targetting organisations operating in life sciences and biotechnology.
Ed Hayden, Director, Guildford, at Scott Brownrigg, said: “Creating this new park is a really exciting opportunity to build upon the successful history of the technology in Cambridge, and we are really thrilled to be designing the next generation of sustainable workplaces to support the growth of world leading creativity in Cambridge”.
Tim Schoen, BioMed Realty CEO, added: “BioMed remains committed to investing in the UK by providing the mission-critical space that is needed to bring life-saving products and therapies to market and ensure the UK’s future success as a global leader in drug development.
“Having engaged and worked closely with local stakeholders to bring our latest development forward, we can now deliver a scheme that will help advance Cambridge as a global home for research while supporting the local economy.”
The client team for the major laboratory complex includes project manager and cost consultant Turner and Townsend, MEP engineer Atelier Ten, and structural engineer Ramboll.
The development is targeting a BREEAM Excellent score and a notable net gain in biodiversity.
The first phase building and car park is expected to be delivered before the end of 2024.
Construction cost is estimated at around £200m.
Are you a building professional? Sign up for a FREE MEMBERSHIP to upload news stories, post job vacancies, and connect with colleagues on our secure social feed.